BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fink U, Stein HJ, Schuhmacher C, Wilke HJ. Neoadjuvant chemotherapy for gastric cancer: update. World J Surg. 1995;19:509-516. [PMID: 7676692 DOI: 10.1007/bf00294711] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Hartmann F, Pfreundschuh M. [Oncology '96]. Med Klin (Munich) 1997;92:83-100. [PMID: 9139216 DOI: 10.1007/BF03042290] [Reference Citation Analysis]
2 Shchepotin IB, Chorny V, Hanfelt J, Evans SR. Palliative superselective intra-arterial chemotherapy for advanced nonresectable gastric cancer. J Gastrointest Surg. 1999;3:426-431. [PMID: 10482696 DOI: 10.1016/s1091-255x(99)80060-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Zhao WH, Wang SF, Ding W, Sheng JM, Ma ZM, Teng LS, Wang M, Wu FS, Luo B. Apoptosis induced by preoperative oral 5’-DFUR administration in gastric adenocarcinoma and its mechanism of action. World J Gastroenterol 2006; 12(9): 1356-1361 [PMID: 16552801 DOI: 10.3748/wjg.v12.i9.1356] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
4 Ge W, Chen G, Fan XS. Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding. Oncotarget 2017;8:41549-54. [PMID: 28099909 DOI: 10.18632/oncotarget.14607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
5 McLoughlin JM. Adenocarcinoma of the stomach: a review. Proc (Bayl Univ Med Cent) 2004;17:391-9. [PMID: 16200126 DOI: 10.1080/08998280.2004.11928001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
6 Elizalde JI, Piñol V, Bessa X, Saló J, Soriano A, Feu F, Castells A. [Role of echoendoscopy in diagnostic and therapeutic strategies in gastrointestinal oncology]. Gastroenterol Hepatol 2002;25:60-9. [PMID: 11835875 DOI: 10.1016/s0210-5705(02)70242-2] [Reference Citation Analysis]
7 Jiang SP, Li ZY, Huang LW, Zhang W, Lu ZQ, Zheng ZY. Multivariate analysis of the risk for pulmonary complication after gastrointestinal surgery. World J Gastroenterol 2005; 11(24): 3735-3741 [PMID: 15968730 DOI: 10.3748/wjg.v11.i24.3735] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
8 Marcus SG, Cohen D, Lin K, Wong K, Thompson S, Rothberger A, Potmesil M, Hiotis S, Newman E. Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer. J Gastrointest Surg. 2003;7:1015-1022; discussion 1023. [PMID: 14675711 DOI: 10.1016/j.gassur.2003.09.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
9 Lowy AM, Mansfield PF, Leach SD, Pazdur R, Dumas P, Ajani JA. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg. 1999;229:303-308. [PMID: 10077040 DOI: 10.1097/00000658-199903000-00001] [Cited by in Crossref: 179] [Cited by in F6Publishing: 160] [Article Influence: 7.8] [Reference Citation Analysis]
10 Sun Z, Zhang N. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. World J Surg Oncol. 2014;12:397. [PMID: 25543664 DOI: 10.1186/1477-7819-12-397] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]